• Fri. Jul 26th, 2024
    • '
    Digital Journal

    Upper Respiratory Tract Infection Treatment Market is estimated to be US$ 28.3 billion by 2032: Increasing Prevalence of Lung Diseases to Propel Market Growth

    author
    3 minutes, 21 seconds Read
    Respiratory tract infections affect the respiratory system, the part of the body responsible for breathing, these infections can affect the sinuses, throat, lungs or airways. While most upper respiratory tract infections are self-diagnosed and self-treated at home, patients who present with a URI often benefit from reassurance, education, and suggestions for symptomatic home treatment. Symptom-based therapy represents the mainstay of URI treatment in immunocompromised adults, although antibiotic or antiviral therapy is appropriate in select patients, several URIs requiring special attention are described in this section. Upper respiratory tract infections, namely sinusitis, otitis media and pharyngitis, are frequent causes of all three disorders, especially chronic sinusitis in adults and otitis media in children. Knowledge of causative pathogens and evolving patterns of drug resistance is essential on which appropriate treatment decisions can be made. The recommended first-line treatment is a 10-day course of penicillin, erythromycin may be used in patients allergic to penicillin. Amoxicillin, azithromycin (Zithromax), and first-generation cephalosporins are suitable options. Because most URIs are caused by viruses, antibiotics are not necessary or helpful treatment is to make yourself comfortable, get plenty of rest, and stay hydrated.  Helpful over-the-counter medications include: nasal sprays or decongestants such as pseudoephedrine (Sudafed). Upper respiratory tract infection is empirically treated with a short course of oral antibiotics, due to increased resistance to penicillin, cephalosporins are commonly prescribed, Cefixime is a third-generation cephalosporin with a gender half-life, a broad spectrum of antibacterial effects, and safe, rapid relief. Symptoms of URTI. Most of the time, viruses cause upper respiratory tract infections, viruses do not respond to antibiotics, you can treat the symptoms at home with pain relievers, rest and drinking fluids. Upper respiratory infections are common and anyone can catch them, although some groups of people are at higher risk of infection, with children at higher risk because they are often around other children who may have the virus. Children may also wash their hands less often than adults, and they are also more likely to put their fingers in their eyes, nose, and mouth, which can spread germs more easily. Rising incidence of upper respiratory tract infection, development of new drugs and increasing demand for over the counter drugs are helping the growth of upper respiratory tract infection treatment industry globally. Factors such as increasing prevalence of lung diseases, increase in geriatric population, and increasing risk of pneumonia in children are expected to drive lucrative growth in the URTI market. Furthermore, the emergence of biologics will positively impact the upper respiratory tract infection treatment market over the Upcoming period.Segmentation:

    Based on Type Upper Respiratory Tract Infection Treatment Market is segmented into

    • Antibiotics
    • Nonsteroidal
    • Anti-Inflamatory Drugs (Nsaids)
    • Nasal Decogestants

    Based on Application, Upper Respiratory Tract Infection Treatment Market is segmented into

    • Hospital Pharmacies
    • Retail Pharmacies
    • Drug Stores
    • Online Pharmacies.

    By Region, the Upper Respiratory Tract Infection Treatment Market is segmented into

    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa.

    Top Players:

    The prominent players operating in the Upper Respiratory Tract Infection Treatment Market includes,

    • GlaxoSmithKline Plc.
    • Alcon, Merck & Co., Inc.
    • Regeneron Pharmaceuticals Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Collegium Pharmaceutical
    • GlaxoSmithKline plc
    • Verona Pharma Plc
    • Pfizer Inc
    • Teva Pharmaceuticals
    • Hospira

    Request Free Sample Report Copy: https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/2389

    About Us

    Prophecy Market Insights is a leading provider of market research services, offering insightful and actionable reports to clients across various industries. With a team of experienced analysts and researchers, Prophecy Market Insights provides accurate and reliable market intelligence, helping businesses make informed decisions and stay ahead of the competition. The company’s research reports cover a wide range of topics, including industry trends, market size, growth opportunities, competitive landscape, and more. Prophecy Market Insights is committed to delivering high-quality research services that help clients achieve their strategic goals and objectives.

    Related report:

    To know more        

    Contact Us:

    Sales

    Prophecy Market Insights

    📞+1 860 531 2574

    ✉ Email– sales@prophecymarketinsights.com

    🌐 Website- www.prophecymarketinsights.com

    🌐 Blog- www.prophecyjournals.com

    Follow us on:

    LinkedIn | Twitter | Facebook

    Your Missed